{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T05:00:27Z","timestamp":1770958827327,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jcf.2022.11.003","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T09:17:53Z","timestamp":1668590273000},"page":"356-362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Estimating the minimum sample size for interventional and observational studies using the lung clearance index as an endpoint\u2730"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9871-281X","authenticated-orcid":false,"given":"Cole","family":"Bowerman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4057-6592","authenticated-orcid":false,"given":"Felix","family":"Ratjen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7931-8051","authenticated-orcid":false,"given":"Sanja","family":"Stanojevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2022.11.003_bib0001","article-title":"Projecting the impact of delayed access to elexacaftor\/tezacaftor\/ivacaftor for people with cystic fibrosis","author":"Stanojevic","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.11.003_bib0002","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jcf.2020.05.012","article-title":"Cystic fibrosis drug trial design in the era of CFTR modulators associated with substantial clinical benefit: stakeholders\u2019 consensus view","volume":"19","author":"De Boeck","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.11.003_bib0003","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/j.lpm.2017.04.012","article-title":"The changing epidemiology and demography of cystic fibrosis","volume":"46","author":"Stephenson","year":"2017","journal-title":"Presse Med"},{"key":"10.1016\/j.jcf.2022.11.003_bib0004","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.chest.2016.06.029","article-title":"Lung clearance index in adults and children with cystic fibrosis","volume":"150","author":"O\u2019Neill","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2022.11.003_bib0005","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1513\/pats.200611-178HT","article-title":"An overview of endpoints for cystic fibrosis clinical trials: one size does not fit all","volume":"4","author":"Rosenfeld","year":"2007","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.jcf.2022.11.003_bib0006","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jcf.2016.05.014","article-title":"Physiologic endpoints for clinical studies for cystic fibrosis","volume":"15","author":"Stanojevic","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.11.003_bib0007","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/MCP.0000000000000418","article-title":"Innovating cystic fibrosis clinical trial designs in an era of successful standard of care therapies","volume":"23","author":"VanDevanter","year":"2017","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jcf.2022.11.003_bib0008","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1136\/thx.2004.022590","article-title":"Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis","volume":"59","author":"Aurora","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2022.11.003_bib0009","article-title":"Reduced bacterial colony count of anaerobic bacteria is associated with a worsening in lung clearance index and inflammation in cystic fibrosis","volume":"10","author":"O'Neill","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcf.2022.11.003_bib0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/thx.2007.082628","article-title":"Lung clearance index is a sensitive, repeatable and practical measure of airways disease in adults with cystic fibrosis","volume":"63","author":"Horsley","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2022.11.003_bib0011","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1164\/rccm.200911-1646OC","article-title":"Lung clearance index at 4 years predicts subsequent lung function in children with cystic fibrosis","volume":"183","author":"Aurora","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2022.11.003_bib0012","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1164\/rccm.201310-1747OC","article-title":"Lung clearance index is a repeatable and sensitive indicator of radiological changes in bronchiectasis","volume":"189","author":"Rowan","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2022.11.003_bib0013","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/ppul.21093","article-title":"Lung clearance index: normal values, repeatability, and reproducibility in healthy children and adolescents","volume":"44","author":"Fuchs","year":"2009","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2022.11.003_bib0014","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01302-2019","article-title":"Normative data for multiple breath washout outcomes in school-aged Caucasian children","volume":"55","author":"Anagnostopoulou","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2022.11.003_bib0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jcf.2013.09.005","article-title":"Lung clearance index: evidence for use in clinical trials in cystic fibrosis","volume":"13","author":"Kent","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.11.003_bib0016","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/1073191116669784","article-title":"How small is big: sample size and skewness","volume":"25","author":"Piovesana","year":"2018","journal-title":"Assessment"},{"key":"10.1016\/j.jcf.2022.11.003_bib0017","series-title":"Points to consider on adjustment for baseline covariates","year":"2003"},{"key":"10.1016\/j.jcf.2022.11.003_bib0018","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1183\/09031936.00072510","article-title":"The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis","volume":"37","author":"Amin","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2022.11.003_bib0019","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1164\/rccm.202102-0509OC","article-title":"A phase 3 open-label study of elexacaftor\/tezacaftor\/ivacaftor in children 6 through 11 years of age with cystic fibrosis and at least one F508del allele","volume":"203","author":"Zemanick","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2022.11.003_bib0020","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00433-2017","article-title":"Inter-test reproducibility of the lung clearance index measured by multiple breath washout","volume":"50","author":"Oude Engberink","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2022.11.003_bib0021","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1164\/rccm.201801-0074ST","article-title":"Preschool multiple-breath washout testing an official American thoracic society technical statement","volume":"197","author":"Robinson","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2022.11.003_bib0022","article-title":"Lung clearance index to track acute respiratory events in school-age children with cystic fibrosis","author":"Perrem","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2022.11.003_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2161-105X.1000392","article-title":"Is lung clearance index (LCI) affected by the severity of lung disease in CF?","volume":"07","author":"Avramidou","year":"2017","journal-title":"J Pulm Respir Med"},{"key":"10.1016\/j.jcf.2022.11.003_bib0024","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S2213-2600(19)30187-0","article-title":"Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"7","author":"Ratjen","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcf.2022.11.003_bib0025","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/ppul.24675","article-title":"Lung clearance index and steroid response in pediatric severe asthma","volume":"55","author":"Irving","year":"2020","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2022.11.003_bib0026","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.rmed.2016.01.020","article-title":"A randomized controlled trial to evaluate the lung clearance index as an outcome measure for early phase studies in patients with cystic fibrosis","volume":"112","author":"Amin","year":"2016","journal-title":"Respir Med"},{"key":"10.1016\/j.jcf.2022.11.003_bib0027","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1164\/rccm.201610-2158OC","article-title":"Progression of lung disease in preschool patients with cystic fibrosis","volume":"195","author":"Stanojevic","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2022.11.003_bib0028","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03380-2020","article-title":"Determinants of lung disease progression measured by lung clearance index in children with cystic fibrosis","volume":"58","author":"Stanojevic","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2022.11.003_bib0029","article-title":"Longitudinal course of clinical lung clearance index in children with cystic fibrosis","author":"Frauchiger","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2022.11.003_bib0030","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jcf.2017.08.004","article-title":"Variability of lung clearance index in clinically stable cystic fibrosis lung disease in school age children","volume":"17","author":"Svedberg","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.11.003_bib0031","first-page":"1148","article-title":"Correction of sensor crosstalk error in Exhalyzer D multiple-breath washout device significantly impacts outcomes in children with cystic fibrosis","volume":"131","author":"Wyler","year":"2021","journal-title":"J Appl Physiol Respir Environ Exerc Physiol"},{"key":"10.1016\/j.jcf.2022.11.003_bib0032","article-title":"Impact of cross-sensitivity error correction on representative nitrogen-based multiple breath washout data from clinical trials","author":"Robinson","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.11.003_bib0033","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jcf.2019.11.006","article-title":"Integrating the multiple breath washout test into international multicentre trials","volume":"19","author":"Saunders","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.11.003_bib0034","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/thx.2009.125831","article-title":"Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function","volume":"65","author":"Amin","year":"2010","journal-title":"ThoraxThorax"},{"key":"10.1016\/j.jcf.2022.11.003_bib0035","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1164\/rccm.201302-0219OC","article-title":"Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline","volume":"188","author":"Subbarao","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2022.11.003_bib0036","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S2213-2600(13)70182-6","article-title":"Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D-CFTR mutation and preserved spirometry: a randomised controlled trial","volume":"1","author":"Davies","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcf.2022.11.003_bib0037","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/thoraxjnl-2017-210979","article-title":"Lung clearance index to monitor treatment response in pulmonary exacerbations in preschool children with cystic fibrosis Cystic fibrosis","volume":"73","author":"Rayment","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2022.11.003_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2021.02.004","article-title":"Withdrawal of dornase alfa increases ventilation inhomogeneity in children with cystic fibrosis","author":"Voldby","year":"2021","journal-title":"J Cyst Fibros"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199322014126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199322014126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:49:38Z","timestamp":1761601778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199322014126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1569199322014126"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2022.11.003","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimating the minimum sample size for interventional and observational studies using the lung clearance index as an endpoint\u2730","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2022.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}